Nucleus Research is a major medical device manufacturer whom chose to adopt Adaptive Insights’ Adaptive Planning for forecasting, planning, and accounting across many of its manufacturing sites. Nucleus found that by adopting Adaptive Planning, the company was able to improve visibility, increase trust in financial forecasts and analysis, provide greater auditability, and increase finance and non-finance employee productivity.
Industry: Medical Technologies
Financial Turn-Around: 4.8 Months
Average Annual Benefit: $165,198
Return on Investment: 299%